HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.

AbstractBACKGROUND & AIMS:
Several lines of evidence suggest that innate immunity plays a key role in hepatic fibrogenesis. To clarify the role of natural killer (NK) T cells in hepatic inflammation and fibrogenesis, we here investigated xenobiotics-induced liver injury and subsequent fibrogenesis in mice lacking mature NKT cells caused by genetic disruption of the CD1d molecule.
METHODS:
Male CD1d-knockout (KO) and wild-type (WT) mice were given repeated intraperitoneal injections of thioacetamide (TAA, 3times/week; 0.1-0.2mg/g BW) for up to 9 weeks, or a single intraperitoneal injection of CCl(4) (1 μl/g). Liver histology was evaluated, and expression levels of cytokines and matrix-related genes in the liver were quantitatively measured by real-time reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS:
Mortality following repeated injections of TAA was prevented almost completely in CD1d-KO mice. TAA-induced inflammatory responses and hepatocellular damage were markedly ameliorated in CD1d-KO mice. TAA-induced expression of smooth muscle α-actin (SMA) and transforming growth factor (TGF)β1 mRNA in the liver were also prevented largely in CD1d-KO mice. In fact, CD1d-KO mice developed minimal hepatic fibrosis after 9-weeks of administration of TAA, which caused overt bridging fibrosis in WT mice. Indeed, TAA-induced increases in α1(I)procollagen (COL1A1) and tissue inhibitor of matrix metalloproteinase (TIMP)-1 mRNA were blunted significantly in CD1d-KO mice. Similarly, acute CCl(4)-induced hepatic injury and subsequent profibrogenic responses were also reduced significantly in CD1d-KO mice.
CONCLUSIONS:
These findings clearly indicated that CD1d-restricted NKT cells contribute to xenobiotics-induced hepatic inflammation, hepatocellular damage, and subsequent profibrogenic responses in the liver.
AuthorsSachiko Ishikawa, Kenichi Ikejima, Hisafumi Yamagata, Tomonori Aoyama, Kazuyoshi Kon, Kumiko Arai, Kazuyoshi Takeda, Sumio Watanabe
JournalJournal of hepatology (J Hepatol) Vol. 54 Issue 6 Pg. 1195-204 (Jun 2011) ISSN: 1600-0641 [Electronic] Netherlands
PMID21145835 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Antigens, CD1d
  • Cd1d1 protein, mouse
  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • RNA, Messenger
  • Tissue Inhibitor of Metalloproteinase-1
  • Thioacetamide
Topics
  • Animals
  • Antigens, CD1d (genetics, metabolism)
  • Base Sequence
  • Cell Death (drug effects, immunology)
  • Chemical and Drug Induced Liver Injury (etiology, genetics, immunology, pathology)
  • Collagen Type I (genetics)
  • Collagen Type I, alpha 1 Chain
  • Hepatocytes (drug effects, immunology, pathology)
  • Immunity, Innate
  • Liver Cirrhosis (etiology, genetics, immunology, pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Natural Killer T-Cells (immunology)
  • RNA, Messenger (genetics, metabolism)
  • Thioacetamide (toxicity)
  • Tissue Inhibitor of Metalloproteinase-1 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: